Migraine Treatment With Nerivio Migra Neurostimulation Device

Stopped early · Not applicable · Has a placebo group

Conditions studied: Acute Migraine

In brief

This is a prospective, randomized, double-blind, sham controlled multi-center trial. Ratio between treatment and control groups will be 1:1, stratified by center and use of preventive medications.

Key facts

Study ID
NCT03076515
Run by
Theranica
People needed
120
Starts
2017-04-02
Expected to finish
2018-04-01
Last updated by the study team
2025-07-17

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.